CN Patent

CN113766930B — Glp1受体的变异核酸文库

Assigned to Twist Bioscience Corp · Expires 2025-07-22 · 1y expired

What this patent protects

本文提供了与胰高血糖素样肽‑1受体(GLP1R)文库有关的方法和组合物，所述文库具有编码包含GLP1R结合域的支架的核酸。本文所述的文库包括斑驳化的文库，其包含各自编码至少一个预定参考核酸序列的预定变体的核酸。本文进一步描述了当翻译所述核酸文库时生成的蛋白质文库。本文进一步描述了表达本文所述的斑驳化核酸文库的细胞文库。

USPTO Abstract

本文提供了与胰高血糖素样肽‑1受体(GLP1R)文库有关的方法和组合物，所述文库具有编码包含GLP1R结合域的支架的核酸。本文所述的文库包括斑驳化的文库，其包含各自编码至少一个预定参考核酸序列的预定变体的核酸。本文进一步描述了当翻译所述核酸文库时生成的蛋白质文库。本文进一步描述了表达本文所述的斑驳化核酸文库的细胞文库。

Drugs covered by this patent

Patent Metadata

Patent number
CN113766930B
Jurisdiction
CN
Classification
—
Expires
2025-07-22
Drug substance claim
No
Drug product claim
No
Assignee
Twist Bioscience Corp
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.